Study area. by Caleb B. Fogel (12858982)

Subjects:

Description of temperature scenarios. by Caleb B. Fogel (12858982)

Subjects:

Individual MSNA changes and correlation with change in BP. by Monique E. A. M. van Kleef (8783282)

The participants’ demographic characteristics. by Shoeleh Rahimi (19065677)

Subjects:

Average change in ATP activity after sulfite treatment. by Sally V. Irwin (4521733)

Subjects:

Results of the difference-in-differences analysis, adjusted for province and size-of-clinic strata, other important variables, and overall; the models included the arm and arm-b-ap... by Neil A. Martinson (8587299)

Results of RF regression model validation and significance of influencing factors (desert area change and spatiotemporal characteristics of ERI). by Mingyue Sun (4638535)

Bi-directional MR results for the four metabolites significant in the interaction QTL analysis. by Ozvan Bocher (13813416)

Subjects:

Correlation analysis of the change of executive functions with the decrease of mobile phone addiction index and the increase of mindfulness level. by Jizhao Li (5856650)

(a) Surface area and volume change with water level; (b) Topographic changes in the Caspian Sea. by Zihao Duan (17403792)

Subjects:

Sample characteristics of the 57 included study participants. by Serhiy Y. Chumachenko (9969725)

Table 6 - Gain and loss: Human and environmental wellbeing – drivers of Kilimanjaro’s decreasing biodiversity by Andreas Hemp (730415)

Distribution of population at final time (left) and change in mean MSI at final time (right) from simulations across 1000 parameter sets when weevils are absent (red) and with weev... by Alexandra M. Campbell (3284094)

Subjects:

<i>Neisseria</i> host interaction homologs meeting significance criteria in analysis of mouse passage samples. by Katherine A. Rhodes (12557806)

OLS regression results, including the interaction between congruity and <i>d</i>-score. by Diana Tran Nhat (22559969)

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Flow diagram of the patient selection into the final analysis. by Zi-Rong Chen (9227618)

Subjects:

Patients’ demographics and clinical parameters. by Zi-Rong Chen (9227618)

Subjects:

Associations between demographic variables, In4_SED and SE changes at 6 and 12 months after 4_SED (<i><i>n</i></i> = 80). by Zi-Rong Chen (9227618)

Subjects:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects: